January 26, 2021 |
Wilmington Healthcare, which provides data, insight and intelligence for pharma and medtech companies, has appointed Pfizer’s former UK Digital Marketing Manager, Mikko Figura, as Head of Digital.
In his new role, Mikko will develop and drive the strategy and execution of our clients’ intelligence-led and data-driven omni-channel programmes. These combine multiple channels, including OnMedica – an online community providing bitesize, evidence-based Continuing Professional Development (CPD) and other content for GPs and specialist doctors.
Mikko joins Wilmington Healthcare from the Brain Tumour Charity where, as Head of Digital, he led a team responsible for delivering digital marketing and communications plans across the organisation for income generation and to support service delivery.
Prior to that, he was UK Digital Marketing Manager for Pfizer, where he developed the digital strategy for its UK Rare Diseases Business Unit, which became one of the company’s most successful digital engagement ventures, with initiatives such as patient mobile apps, interactive digital detail aids for sales representatives, and a series of multichannel marketing campaigns.
He also led a team of cross functional stakeholders and external agencies to deliver a consumer-facing multichannel awareness campaign for a rare disease, winning a Pfizer global innovation award in the process.
Mikko has also held roles in digital marketing, customer acquisition, and supporter retention at organisations across a range of industries, including publishing, politics, and B2B service delivery.
Simon Grime, of Wilmington Healthcare, says: “We’re delighted to have Mikko on the team and, having worked in both the pharma and healthcare charity sectors, he brings a really valuable blend of digital marketing experience to his new post.
“He will be a fantastic addition to the company, where he will play a key role in shaping our intelligence-led omni-channel marketing strategy and helping our clients deliver the optimal mix of channels to complement their customer engagement strategies.”
Ends
This content was provided by Wilmington Healthcare
Company Details
Latest Content from Wilmington Healthcare
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare
Paul Midgley, Sue Thomas, Steve How and Oli Hudson, of Wilmington Healthcare, explore how pharma should adapt its approach
HSJ Awards open for entry with promise to champion NHS on its 70th anniversary
Following the ransomware attack that wreaked havoc on NHS IT systems last year and resulted in major disruption to patient care, the majority of doctors surveyed by healthcare intelligence provider...
Winners include pharma, medtech, healthcare consultants and IT specialists. Innovative pharma and medtech companies have been honoured in an awards scheme run by Health Service Journal (HSJ), the news and...
Steve How, Paul Midgley and Sue Thomas, of Wilmington Healthcare, explore population-based planning in the NHS and what this means for pharma
Steve How, Paul Midgley and Sue Thomas, of Wilmington Healthcare, explore how pharma should respond to the NHS’s move towards more collaborative, joined up working
The finalists for the first HSJ Healthcare Partnership Awards have been announced. The awards serve to recognise and celebrate those suppliers who work in partnerships with the NHS to drive...
Sue Thomas and Paul Midgley, of Wilmington Healthcare, explore how the proposed national patient data sharing scheme would change the NHS
The recent announcement by Health Secretary Jeremy Hunt on which Sustainability and Transformation Partnerships (STPs) would benefit from a share of the £325m capital funding allocated in the Spring Budget,...